Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Gh Research Plc (NQ: GHRS ) 14.09 +0.56 (+4.14%) Streaming Delayed Price Updated: 4:00 PM EDT, May 31, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Gh Research Plc < Previous 1 2 3 4 5 6 7 8 9 ... 16 17 Next > 2 Psychedelics Companies Tout Advanced Clinical Trials, Progress With Key Products January 11, 2023 Two psychedelics companies have shared their updates and key milestones to be reached this 2023. Via Benzinga Psychedelic Stock Gainers And Losers From January 10, 2023 January 10, 2023 Via Benzinga Psychedelic Stock Gainers And Losers From January 9, 2023 January 09, 2023 Via Benzinga GH Research Provides Business Updates and Highlights Key Upcoming Milestones January 09, 2023 From GH Research PLC Via GlobeNewswire My "Rags-To-Riches" Portfolio For 2023: An Introduction January 08, 2023 The performance of cannabis, psychedelic and plant-based food stocks in 2022 were just horrible; is there any way to go but up? Via Talk Markets ATAI Life Sciences, Cybin Among Top Psychedelic Movers Of Today January 06, 2023 Via Benzinga Psychedelic Stock Gainers And Losers From January 5, 2023 January 05, 2023 Via Benzinga Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today January 04, 2023 Via Benzinga Psychedelic Stock Gainers And Losers From January 3, 2023 January 03, 2023 Via Benzinga Psychedelic Stock Gainers And Losers From January 2, 2023 January 02, 2023 Via Benzinga 6 Largest Psychedelic Drug Stocks Were -20% In December January 02, 2023 The Psychedelic Drug Stocks Index, which tracks the six largest psychedelic stocks researching the treatment of mental illnesses based on the use of one or more psychedelic substances, continued to... Via Talk Markets Psychedelic Stock Gainers And Losers From December 30, 2022 December 30, 2022 Via Benzinga Psychedelic Stock Gainers And Losers From December 29, 2022 December 29, 2022 Via Benzinga Psychedelic Stock Gainers And Losers From December 28, 2022 December 28, 2022 Via Benzinga Psychedelic Stock Gainers And Losers From December 27, 2022 December 27, 2022 Via Benzinga Psychedelic Stock Gainers And Losers From December 26, 2022 December 26, 2022 Via Benzinga Psychedelic Stock Gainers And Losers From December 23, 2022 December 23, 2022 Via Benzinga Largest Psychedelic Stocks -7.6% This Week; Now -21.7% This Month December 25, 2022 Highlighting the performance of the six stocks in our Psychedelic Drug Stocks Index, which are researching the treatment of mental illnesses using 10 different psychedelic substances. Via Talk Markets Cybin, ATAI Life Sciences Among Top Psychedelic Movers Of Today December 22, 2022 Via Benzinga Psychedelic Stock Gainers And Losers From December 21, 2022 December 21, 2022 Via Benzinga GH Research, Seelos Therapeutics Among Top Psychedelic Movers Of Today December 20, 2022 Via Benzinga Psychedelic Stock Gainers And Losers From December 19, 2022 December 19, 2022 Via Benzinga Major Psychedelic Drug Stocks Down Another 7% This Week; Now Down 54% YTD December 18, 2022 The 6 largest psychedelic stocks that research the treatment of a variety of mental illnesses based on the use of 10 different psychedelic substances are down again this week. Via Talk Markets Psychedelic Stock Gainers And Losers From December 14, 2022 December 14, 2022 Via Benzinga Psychedelic Stock Gainers And Losers From December 13, 2022 December 13, 2022 Via Benzinga Seelos Therapeutics, Mind Medicine Among Top Psychedelic Movers Of Today December 16, 2022 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2022 December 16, 2022 Via Benzinga Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today December 15, 2022 Via Benzinga Psychedelic Stock Gainers And Losers From December 12, 2022 December 12, 2022 Via Benzinga Major Psychedelic Drug Stocks DOWN 9% Last Week; Now Down 51% YTD December 11, 2022 Today's article highlights the performance of the largest psychedelic stocks that research the treatment of a variety of mental illnesses based on the use of ten (10) different psychedelic substances. Via Talk Markets < Previous 1 2 3 4 5 6 7 8 9 ... 16 17 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.